Tape medical adhesive plastic perforated
Reference: TPS12
Type: Top Proven Switch Start Date: 20 January 2019
Expiry Date: While stock lasts
Type: Top Proven Switch Start Date: 20 January 2019
Expiry Date: While stock lasts
- Primary NPC – EHA053
- Comparable NPC – EHA020 and EHA044
- Price difference – 32%
- Trusts already purchasing – 250
- Contract – General Wound Care
In Walsall we have a wound care group that meet monthly to look at cost effective options for formulary. We were approached by the clinical procurement nurse with Blue Dot plastic perforated tape as a cheaper alternative to Transpore. After brief review in the meeting samples were given to the vascular nurse and community nurse. Both tried the product and were happy to confirm that it performed well in their clinical practice. With this feedback the group will now recommend this is the preferred option for plastic tape moving forward.Lisa Turley, Tissue Viability Lead Nurse
Walsall Healthcare NHS Trust
SWBH undertook an evaluation of the Blue Dot/Crest Medical plastic medical tape 2.5cm on our Critical Care unit over a period of two weeks. Clinicians response was positive and they felt this tape was equivalent to the Transpore tape they were currently using. The switch was made throughout the Trust on 1 July 2017 and to date we haven’t received any complaints or negative feedback regarding the product.Lisa Southall, NHS Supply Chain and Procurement Supervisor
Procurement Department - SWBH Trust
‘Proven Switch’ definition: based on an alternative already adopted by some NHS Supply Chain customer(s), which offer the largest potential savings nationally (i.e. across all of NHS Supply Chain’s customers). Identified based on the purchase history of customers, where the sales have stopped on the primary product and then started on the identified alternative product. Forecasted savings have been calculated based on the band 1 price of the primary product (i.e. the products currently used by trusts) minus the band 1 price of the alternative product multiplied by the last 12 months actual quantity purchased where a switch has been detected (switch: where sales have stopped on the primary product and then started on the identified alternative product). Potential savings have been calculated based on the band 1 price of the primary product (i.e. the products currently used by trusts) minus the band 1 price of the alternative product multiplied by the last 12 months actual quantity purchased. ‘No of trusts purchasing comparable products’ refers to NHS Supply Chain customers who already purchase the alternative product, this does not reflect the number of trusts who have made the switch from the primary to the alternative product. Trusts should check with clinical teams that the alternative product is suitable for its dedicated use in each instance. All savings and prices correct at time of publication. Read More / Read Less… »